mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for SRY
Gene summary
Basic gene Info.Gene symbolSRY
Gene namesex determining region Y
SynonymsSRXX1|SRXY1|TDF|TDY
CytomapUCSC genome browser: Yp11.3
Type of geneprotein-coding
RefGenesNM_003140.2,
Descriptionessential protein for sex determination in human malessex determining region Y proteinsex-determining region Y proteinsex-determining region on Ytestis-determining factor on Y
Modification date20141219
dbXrefs MIM : 480000
HGNC : HGNC
Ensembl : ENSG00000184895
HPRD : 08364
Vega : OTTHUMG00000036084
ProteinUniProt: Q05066
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_SRY
BioGPS: 6736
PathwayNCI Pathway Interaction Database: SRY
KEGG: SRY
REACTOME: SRY
Pathway Commons: SRY
ContextiHOP: SRY
ligand binding site mutation search in PubMed: SRY
UCL Cancer Institute: SRY
Assigned class in mutLBSgeneDBA: This gene has a literature evidence and it belongs to targetable_mutLBSgenes.
References showing study about ligand binding site mutation for SRY.1. "Bolzon C, Joonè CJ, Schulman ML, Harper CK, Villagómez DA, King WA, Révay T. Missense Mutation in the Ligand-Binding Domain of the Horse Androgen Receptor Gene in a Thoroughbred Family with Inherited 64,XY (SRY+) Disorder of Sex Development. Sex Dev. 2016;10(1):37-44. doi: 10.1159/000444991. Epub 2016 Apr 14." 27073903

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0006357regulation of transcription from RNA polymerase II promoter21412441
GO:0006366transcription from RNA polymerase II promoter21412441
GO:0045893positive regulation of transcription, DNA-templated21412441
GO:2000020positive regulation of male gonad development21412441


Top
Ligand binding site mutations for SRY
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
R86R86QSKCM1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for SRY
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R86R86Q-1.006487
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for SRY from PDB

Top
Differential gene expression and gene-gene network for SRY
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of SRY and the right PPI network was created from samples without mutations in the LBS of SRY. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for SRY
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C274889646,Xy Gonadal Dysgenesis, Complete, Sry-Related22Biomarker, GeneticVariation
umls:C2748895Ovotesticular Disorders of Sex Development5Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for SRY
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of SRY go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of SRY
Multiple alignments for Q05066 in multiple species
LBSAA sequence# speciesSpecies
F110EKWPFFQEAQK2Homo sapiens, Pan troglodytes
F110EKRPFFEEAQR1Bos taurus
F67RPMNAFIVWSR2Homo sapiens, Bos taurus
F67RPMNAFFVWSR1Pan troglodytes
G95ISKQLGYQWKM2Homo sapiens, Pan troglodytes
G95ISKQLGYEWKR1Bos taurus
I68PMNAFIVWSRD1Homo sapiens
I68PMNAFIVWSRE1Bos taurus
I68PMNAFFVWSRD1Pan troglodytes
K106LTEAEKWPFFQ2Homo sapiens, Pan troglodytes
K106LTDAEKRPFFE1Bos taurus
K128KYPNYKYRPRR2Homo sapiens, Pan troglodytes
K128KYPGYKYRPRR1Bos taurus
K134YRPRRKAKMLP1Homo sapiens
K134YRPRRRAKRPQ1Bos taurus
K134YRPRRKANMLP1Pan troglodytes
K136PRRKAKMLPKN1Homo sapiens
K136PRRRAKRPQKS1Bos taurus
K136PRRKANMLPKN1Pan troglodytes
K61VQDRVKRPMNA2Homo sapiens, Pan troglodytes
K61SQDHVKRPMNA1Bos taurus
K92NSEISKQLGYQ2Homo sapiens, Pan troglodytes
K92NSDISKQLGYE1Bos taurus
K99LGYQWKMLTEA2Homo sapiens, Pan troglodytes
K99LGYEWKRLTDA1Bos taurus
M64RVKRPMNAFIV1Homo sapiens
M64HVKRPMNAFIV1Bos taurus
M64RVKRPMNAFFV1Pan troglodytes
M85LENPRMRNSEI2Homo sapiens, Pan troglodytes
M85LENPKMKNSDI1Bos taurus
N65VKRPMNAFIVW2Homo sapiens, Bos taurus
N65VKRPMNAFFVW1Pan troglodytes
N87NPRMRNSEISK2Homo sapiens, Pan troglodytes
N87NPKMKNSDISK1Bos taurus
P131NYKYRPRRKAK1Homo sapiens
P131GYKYRPRRRAK1Bos taurus
P131NYKYRPRRKAN1Pan troglodytes
P83MALENPRMRNS2Homo sapiens, Pan troglodytes
P83VALENPKMKNS1Bos taurus
Q117EAQKLQAMHRE2Homo sapiens, Pan troglodytes
Q117EAQRLLAIHRD1Bos taurus
R121LQAMHREKYPN2Homo sapiens, Pan troglodytes
R121LLAIHRDKYPG1Bos taurus
R132YKYRPRRKAKM1Homo sapiens
R132YKYRPRRRAKR1Bos taurus
R132YKYRPRRKANM1Pan troglodytes
R133KYRPRRKAKML1Homo sapiens
R133KYRPRRRAKRP1Bos taurus
R133KYRPRRKANML1Pan troglodytes
R59GNVQDRVKRPM1Homo sapiens
R59ESSQDHVKRPM1Bos taurus
R59DSVQDRVKRPM1Pan troglodytes
R62QDRVKRPMNAF2Homo sapiens, Pan troglodytes
R62QDHVKRPMNAF1Bos taurus
R72FIVWSRDQRRK1Homo sapiens
R72FIVWSRERRRK1Bos taurus
R72FFVWSRDQRRK1Pan troglodytes
R75WSRDQRRKMAL2Homo sapiens, Pan troglodytes
R75WSRERRRKVAL1Bos taurus
R76SRDQRRKMALE2Homo sapiens, Pan troglodytes
R76SRERRRKVALE1Bos taurus
R86ENPRMRNSEIS2Homo sapiens, Pan troglodytes
R86ENPKMKNSDIS1Bos taurus
S88PRMRNSEISKQ2Homo sapiens, Pan troglodytes
S88PKMKNSDISKQ1Bos taurus
S91RNSEISKQLGY2Homo sapiens, Pan troglodytes
S91KNSDISKQLGY1Bos taurus
W98QLGYQWKMLTE2Homo sapiens, Pan troglodytes
W98QLGYEWKRLTD1Bos taurus
Y129YPNYKYRPRRK2Homo sapiens, Pan troglodytes
Y129YPGYKYRPRRR1Bos taurus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas